Thank you for reading the news about Malaysia’s COVID-19 vaccination drive to start next month as cases soar and now with the details
Jeddah - Yasmine El Tohamy - LONDON: Oxford University researchers are planning to trial a drug that has shown signs of reducing COVID-19 deaths in developing countries.
The Principle trial is aiming to find a drug that works soon after virus symptoms appear in a patient, and one that is most effective during the primary stages of the illness, The Times reported.
The trial is assessing Ivermectin, a medicine used on livestock and people who have been infected by parasitic worms, which has been hailed by some as a “wonder drug” with the potential to save thousands of lives, the report added.
Other scientists said the drug had not been assessed properly and that the full extent of its efficacy was not yet known.
“It has potential antiviral properties and anti-inflammatory properties and there have been quite a few smaller trials conducted in low and middle- income countries, showing that it speeds recovery, reduces inflammation and reduces hospitalisation,” said Chris Butler, professor of primary care at Oxford and co-chief of the Principle trial. “But there’s a gap in the data. There’s not been a really rigorous trial.”
The medicine works by blocking the entry of a protein into a cell’s nuclei, limiting the replication capacity of the virus, and initial analysis from the World Health Organization has shown promising signs.
“It could save thousands of lives a day,” said Paul Marik, from the Eastern Virginia Medical School. “The data is compelling: across Mexico, India and South America, mortality has fallen.”
Peter Horby, the Oxford University professor who helped to set up the UK’s largest COVID-19 trials, said this month the latest data was “interesting, perhaps encouraging, but not yet convincing.”
Most breakthroughs in coronavirus treatments to date work on patients who are already suffering in the later stages of the illness, but Butler and his team are hoping to find a medicine that can prevent the virus from taking hold within its host.
The trial is looking for people aged 65 and over, or those aged over 50 who have underlying health conditions, through general practitioners, online, and through the UK’s NHS Test and Trace system, The Times said.
These were the details of the news Malaysia’s COVID-19 vaccination drive to start next month as cases soar for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Arab News and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.